Hear directly from local medical professionals as they discuss prostate cancer and treatments. Hear directly from local medical professionals as they discuss prostate cancer and treatments right here ...

Every year, thousands of cancer patients forgo life-extending therapies because they live too far from treatment centers. United Theranostics is on a mission to change that, permanently. United ...

Cancer treatment is entering a new era, driven by advances in precision medicine, AI, and targeted therapies known as theranostics. In this episode of Today in Tech, Keith Shaw speaks with Douglas ...

A world-first trial of Australian men has confirmed a specialised scan can accurately “light up” prostate cancer, saving unnecessary and painful biopsies and stress of over-diagnosis.

A new partnership will create a theranostics health care platform in the region with radiopharmaceutical production and therapy, molecular imaging, and clinical trials all at the same location. One ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...

SYDNEY, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology ...

The MarketWatch News Department was not involved in the creation of this content. ISTANBUL, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Memorial i li Hospital's (part of Memorial Hospitals Group) Nuclear ...

Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic body radiotherapy (SBRT) went more than twice as long without their disease ...